Microbiota of dogs with and without myxomatous mitral valve disease

In this study, 16S V3-V4 microbiota sequencing was performed on dogs with congestive heart failure (n = 38), dogs in the preclinical stage of the disease (n = 23) and healthy controls with no apparent heart disease (n = 17).